Cargando…
DC-Derived Exosomes for Cancer Immunotherapy
SIMPLE SUMMARY: Dendritic cells (DCs)-based cancer vaccines have not succeeded in generating significant clinical responses despite their capacity to induce host anti-tumor CD8 T cell immunity, and one major hurdle is tumor-mediated immunosuppression. Exosomes are nano-sized inert membrane vesicles...
Autores principales: | Yao, Yi, Fu, Chunmei, Zhou, Li, Mi, Qing-Sheng, Jiang, Aimin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8345209/ https://www.ncbi.nlm.nih.gov/pubmed/34359569 http://dx.doi.org/10.3390/cancers13153667 |
Ejemplares similares
-
DC-Based Vaccines for Cancer Immunotherapy
por: Fu, Chunmei, et al.
Publicado: (2020) -
Plasmacytoid Dendritic Cells and Cancer Immunotherapy
por: Fu, Chunmei, et al.
Publicado: (2022) -
Dendritic Cell-Derived Exosomes in Cancer Immunotherapy
por: Luo, Shumin, et al.
Publicado: (2023) -
DC-targeting lentivectors for cancer immunotherapy
por: Gea-Mallorquí, Ester, et al.
Publicado: (2023) -
Tumor-Derived Exosomes in Immunosuppression and Immunotherapy
por: Olejarz, Wioletta, et al.
Publicado: (2020)